Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Prevalence of Risk Factors for the Development of Bacteraemia in Children Publisher



Mojtahedi SY1 ; Rahbarimanesh A2 ; Khedmat L3 ; Izadi A2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Pediatric Nephrology, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pediatric Infection Disease, Bahrami Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

Source: Open Access Macedonian Journal of Medical Sciences Published:2018


Abstract

AIM: The objective of this study was to evaluate the frequency of risk factors for bacteremia in children less than 15 years of age was determined in Bahrami Hospital during 2013-2016. METHODS: This study conducted on 84 children aged 3 months’ to15 years old, who hospitalised in the pediatrics ward and the PICU in Bahrami Hospital from 2012 to 2016. Our study consisted of 46 boys (54.2%) and 38 girls. Moreover, 24.1% of subjects (20 patients) were entered in the study as young as three months old, followed by three months to three years (49.4 %; 41 subjects), and 3 to 15 years of age (26.5%; 22 individuals). RESULTS: The average hospitalization duration was determined to be 15.30 ± 8.75 days. Moreover, our results revealed that a history of blood transfusion in 11.2% of patients. On the other hand, 35.7% of cases were determined to be positive for blood cultures. The microorganisms reported from positive blood cultures include Enterobacter (81.48%), Escherichia coli (11.11%) and Klebsiella (3.70%). Also, 50% of patients were hospitalised in the internal ward, 12% received immunosuppressive drugs, and 96.4% of the patients had a history of vaccination. CONCLUSION: Pediatric severe sepsis remains a burdensome public health problem, with prevalence, morbidity, and mortality rates similar to those reported in critically ill adult populations. International clinical trials targeting children with severe sepsis are warranted. © 2018 Sayed Yousef Mojtahedi, Aliakbar Rahbarimanesh, Leila Khedmat, Anahita Izadi.